FDA Approves ‘Landmark’ Cancer Drug That Extended Patients’ Lives in Trial

The Food and Drug Administration announced Wednesday the approval of a new pancreatic cancer treatment drug that nearly doubles patients’ survival times. Former GOP Sen. Ben Sasse of Nebraska has seen very positive results using it while it was still in its experimental phase. The drug, known as Rasonque, “a tablet taken once daily, targets multiple forms […] The post FDA Approves ‘Landmark’…